全球磁粒子成像市场规模、份额和趋势分析报告 – 行业概况和 2031 年预测

磁粒子成像市场分析

磁粒子成像 (MPI) 是一种新兴的成像技术，可在不使用电离辐射的情况下提供高分辨率和定量成像。MPI 的最新进展包括开发新的超顺磁性纳米粒子，从而提高图像质量和分辨率。这些纳米粒子可以根据特定应用进行定制，例如检测癌细胞或监测心血管疾病。

MPI 系统的最新创新重点是集成机器学习算法，提高成像速度和准确性。该技术可以实现实时成像，大大缩短诊断所需的时间，这在紧急医疗环境中至关重要。

MPI 在临床和临床前研究环境中的使用正在迅速增长，这得益于它比MRI和CT 扫描仪等传统成像技术具有优势。它提供更高的空间分辨率和在细胞水平上可视化功能过程的能力。

由于研发投入不断增加、慢性病患病率不断上升以及对先进诊断工具的需求不断增加，磁粒子成像市场预计将大幅扩张。随着全球医疗保健系统寻求非侵入式高效成像解决方案，MPI 有望在未来的医疗诊断中发挥关键作用。

磁粒子成像市场规模

2023 年全球磁性粒子成像市场规模价值 5 亿美元，预计到 2031 年将达到 14.5864 亿美元，2024 年至 2031 年预测期内的复合年增长率为 14.32%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

磁粒子成像市场趋势

“临床应用日益普及”

The magnetic particle imaging (MPI) market is witnessing a significant trend toward increasing adoption in clinical applications, particularly in cancer diagnostics and imaging. MPI offers high-resolution imaging without the harmful effects of ionizing radiation, making it an attractive alternative to traditional imaging methods such as MRI and CT scans. For instance, a recent study highlighted MPI’s capability to detect cancerous cells at much lower concentrations than conventional imaging techniques. As more research validates MPI's effectiveness and safety in clinical settings, hospitals and medical facilities are investing in MPI technology, driving market growth and expanding its potential for early disease detection and personalized treatment planning.

Report Scope and Magnetic Particle Imaging Market Segmentation  

Magnetic Particle Imaging Market Definition

Magnetic Particle Imaging (MPI) is an advanced imaging technique that utilizes superparamagnetic nanoparticles as tracers to visualize structures and processes in three dimensions. It operates on the principle of magnetization, allowing for real-time imaging without the ionizing radiation associated with traditional methods such as X-rays or CT scans. MPI offers high spatial resolution and contrast, making it particularly useful in biomedical applications, such as tracking drug delivery and studying vascular systems. This innovative approach is gaining attention for its potential in clinical diagnostics and research, offering a safer and more efficient alternative for visualizing biological processes.

Magnetic Particle Imaging Market Dynamics

Drivers

• Growing Demand for Non-Invasive Imaging

The magnetic particle imaging (MPI) market is significantly driven by the increasing demand for non-invasive imaging techniques. MPI allows for the visualization of biological tissues without the need for surgery or other invasive procedures, making it particularly valuable in medical diagnostics. For instance, MPI can be utilized in oncology for early cancer detection, enabling healthcare providers to monitor tumor growth and treatment response without subjecting patients to the risks associated with traditional imaging methods. This non-invasive approach not only improves patient comfort but also enhances diagnostic accuracy, contributing to the growing acceptance and adoption of MPI in clinical settings worldwide.

• Rising Incidence of Chronic Diseases

The increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, significantly boosts the demand for advanced imaging technologies such as magnetic particle imaging (MPI). For instance, the World Health Organization (WHO) projects that cancer cases will rise to 29.5 million by 2040, necessitating improved diagnostic tools for early detection and treatment monitoring. MPI, with its high spatial resolution and non-invasive nature, is well-suited for visualizing tumor progression and assessing therapeutic efficacy. In addition, as conditions such as Alzheimer's disease become more common, MPI's capability to provide real-time insights into brain activity further enhances its appeal, driving market growth in the healthcare sector.

Opportunities

• Increasing Focus on Personalized Medicine

The increasing focus on personalized medicine creates significant opportunities in the magnetic particle imaging (MPI) market. MPI's capacity to visualize specific biological processes at the cellular level allows for tailored treatment strategies, enabling healthcare providers to deliver more effective therapies. For instance, MPI can track the distribution and effectiveness of targeted therapies in cancer patients, ensuring that the right drug reaches the intended site. Moreover, as pharmaceutical companies invest in personalized treatment solutions, the demand for advanced imaging techniques such as MPI is expected to rise, fostering collaborations between MPI technology developers and clinical research organizations, thereby expanding market potential.

• Advancements in Nanotechnology

The emergence of superparamagnetic nanoparticles is revolutionizing the magnetic particle imaging (MPI) market, significantly enhancing imaging efficacy and resolution. These nanoparticles, characterized by their superparamagnetic properties, allow for better contrast and clearer images, facilitating early disease detection and monitoring. For instance, studies demonstrate that superparamagnetic iron oxide nanoparticles can effectively target and visualize tumors, improving diagnostic accuracy in oncology. This technological advancement not only opens up new research avenues in fields such as drug delivery and molecular imaging but also encourages partnerships between academia and industry, further propelling the development and commercialization of MPI technologies.

Restraints/Challenges

• High Development Costs

High development costs significantly hinder the magnetic particle imaging (MPI) market. The initial investment required for advanced materials, imaging systems, and technology development is substantial, often reaching millions of dollars. This financial burden can deter small and medium-sized enterprises from entering the market, leading to a concentration of resources among a few large players. As a result, innovation may stagnate, and competition becomes limited. Furthermore, the high costs can restrict research and development initiatives, preventing the exploration of new applications and advancements in MPI technology. Consequently, these economic challenges stifle the market's growth potential and slow the adoption of MPI in clinical settings.   

• Competition from Established Imaging Modalities

磁粒子成像 (MPI) 市场面临着来自 MRI 和 CT 等成熟成像方式的激烈竞争。这些技术长期以来一直受到医疗保健提供商的信任，并已深入融入临床实践。它们的广​​泛接受意味着 MPI 必须克服巨大的惯性才能在医学界获得关注。医疗保健提供商可能会因为对可靠性、成本和培训的担忧而犹豫是否采用新技术。此外，MRI 和 CT 的熟悉度和广泛的研究使得 MPI 难以有效展示其优势。因此，这种竞争阻碍了 MPI 的市场增长和在临床环境中的采用。

本市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需获取更多市场信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

磁粒子成像市场范围

市场根据类型、模式、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 追踪者
• MPI 扫描仪
• 其他的

情态

• 磁共振成像
• 正电子发射断层扫描

应用

• 血管成像
• 灌注成像
• 血池成像
• 神经影像学
• 局部高温
• 肿瘤影像
• 细胞追踪
• 炎症成像
• 创伤成像

 最终用户

• 医院
• 专科诊所

磁粒子成像市场区域分析

对市场进行了分析，并按上述国家、类型、模式、应用和最终用户提供了市场规模洞察和趋势。

市场报告涵盖的国家包括北美洲的美国、加拿大、墨西哥、德国、瑞典、波兰、丹麦、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、新西兰、越南、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、巴西、阿根廷、南美洲其他地区（南美洲的一部分）、阿联酋、沙特阿拉伯、阿曼、卡塔尔、科威特、南非、中东和非洲 (MEA) 的其他地区（中东和非洲 (MEA) 的一部分）

由于先进技术（尤其是 3D 打印器官）的快速普及，北美有望在磁粒子成像市场占据主导地位。这一增长得益于该地区持续的研究计划、强大的医疗保健基础设施以及对医学成像创新的不断投资。

预计亚太地区磁粒子成像市场在预测期内将出现丰厚的增长。医疗保健行业的进步和慢性病患者人数的增加推动了这一增长，从而导致对创新诊断技术的需求增加。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

磁粒子成像市场份额

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

在市场上运营的磁粒子成像市场领导者是：

• 布鲁克 (美国)
• Magnetic Insight, Inc.（美国）
• 富士胶片控股株式会社（日本）
• Mediso Ltd.（匈牙利）
• MILabs BV（荷兰）
• Northridge Tri-Modality Imaging, Inc.（美国）
• 通用电气（美国）
• Koninklijke Philips NV（荷兰）
• MR Solutions（英国）
• Mirion Technologies, Inc.（美国）
• BERTHOLD TECHNOLOGIES GmbH & Co. KG（德国）
• 富士胶片医疗欧洲（英国）
• LI-COR Inc.（美国）
• Angstrom Advanced Inc.（美国）
• Pure Devices GmbH (德国)
• Miltenyi Biotec（德国）
• CMR Naviscan（美国）
• Perkin Elmer（美国）
• COMSOL（美国）

SKU-47819